GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Lisa Stiffler on Sep 10, 2024 at ...

Built on unique RNA science and cutting-edge AI, Viome's at-home test redefines health by analyzing 100 million biomarkers to detect early signs of biological dysfunction linked to 25+ chronic health ...

Forbes contributors publish independent expert analyses and insights. Steven covers accessibility and assistive technologies. One of the most fundamental accessibility benefits of this ...

Inside our bodies lies a flourishing ecosystem of microorganisms. This microbiome of bacteria and viruses has a powerful impact on our health, but the exact nuances of how are still being filled in.

Study aims to enhance colorectal cancer prevention by identifying polyp molecular signals, offering improved sensitivity over at-home DNA tests, which have limited ability to detect precancerous ...

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Taylor Soper on Aug 18, 2023 at 7:21 ...

Viome Life Sciences, a biotechnology company, received $86.5 million in an oversubscribed Series C funding round, which it will use to grow its business, the company announced Friday. The Bellevue, ...

Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader in accelerating the impact of fundamental research on human health, today ...

While each product featured is independently selected by our editors, we may include paid promotion. If you buy something through our links, we may earn commission. Read more about our Product Review ...

More than half of adult in the United States have at least ine chronic condition, and more than a quarter have multiple. That includes arthritis, cancer, chronic obstructive pulmonary disease (COPD), ...

Biotechnology company Viome Life Sciences will be expanding its development of direct-to-consumer diagnostic tests and wellness products after receiving $67 million in series C funding, the startup ...